Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,254 | 34,248 | 30,423 | 20,759 | 33,779 |
| Marketable Securities | 152,124 | 162,915 | 192,785 | 186,089 | 197,734 |
| Receivables | 1,014 | 863 | 1,378 | 233 | 182 |
| TOTAL | $183,076 | $206,464 | $230,935 | $216,085 | $238,277 |
| Non-Current Assets | |||||
| PPE Net | 42,152 | 42,623 | 42,634 | 43,515 | 44,526 |
| Intangibles | 98,100 | 98,100 | 98,100 | 98,100 | 98,100 |
| Other Non-Current Assets | 65 | 88 | 109 | 135 | 157 |
| TOTAL | $140,317 | $140,811 | $140,843 | $141,750 | $142,783 |
| Total Assets | $323,393 | $347,275 | $371,778 | $357,835 | $381,060 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 22,678 | 1,607 | 1,574 | 1,542 | 1,510 |
| Accounts payable and accrued liabilities | 6,281 | 5,442 | 7,661 | 4,306 | 4,579 |
| Accrued Expenses | 11,321 | 9,704 | 8,922 | 12,782 | 15,045 |
| TOTAL | $40,903 | $17,381 | $18,285 | $19,051 | $21,555 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 21,457 | 21,877 | 22,284 | 22,678 |
| Deferred Revenues | 623 | 628 | 128 | 421 | 421 |
| Other Non-Current Liabilities | 35,256 | 34,079 | 32,283 | 31,086 | 59,276 |
| TOTAL | $67,406 | $87,686 | $86,815 | $86,025 | $114,609 |
| Total Liabilities | $108,309 | $105,067 | $105,100 | $105,076 | $136,164 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,373 | 73,311 | 73,308 | 73,218 | 70,641 |
| Common Shares | 514 | 514 | 512 | 495 | 481 |
| Retained earnings | -954,886 | -925,806 | -899,832 | -874,959 | -845,420 |
| Other shareholders' equity | 528 | 539 | 393 | 391 | 350 |
| TOTAL | $215,084 | $242,208 | $266,678 | $252,759 | $244,896 |
| Total Liabilities And Equity | $323,393 | $347,275 | $371,778 | $357,835 | $381,060 |